Assessment of Treatment Satisfaction in Psoriasis

Summary

This study aims to validate a patient-reported, dermatology-specific treatment satisfaction instrument (DermSat) for longitudinal assessment in psoriasis patients and to determine its predictive validity for medication adherence and treatment changes.

What they want

The overarching goal is to validate DermSat. Aim 1 involves validating DermSat for longitudinal assessment of patient satisfaction with psoriasis treatments during stable psoriasis and flares, and determining its reliability, using a prospective, observational cohort recruited from a diverse psoriasis patient population in southern California. Aim 2 will determine whether DermSat predicts medication adherence and treatment changes by evaluating its predictive validity through examining its relationship with subsequent assessments of adherence and treatment changes.

Deliverables

A valid and reliable dermatology-specific treatment satisfaction instrument (DermSat)
Study findings impacting future clinical trial design